Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

Cardinal Formally Investigated By SEC

This article was originally published in The Pink Sheet Daily

  • News
  • Lee Kalowski

Executive Summary

A Securities & Exchange Commission investigation into Cardinal's accounting practices began in October. The wholesaler is conducting an independent review.

You may also be interested in...



Cardinal Records $25 Mil. Reserve For Potential SEC Settlement

The wholesaler has entered into settlement negotiations with the SEC related to an investigation of revenue bookings from vitamin price-fixing litigation.

Cardinal Records $25 Mil. Reserve For Potential SEC Settlement

The wholesaler has entered into settlement negotiations with the SEC related to an investigation of revenue bookings from vitamin price-fixing litigation.

Audit Cmte. Sanctions Cardinal Officers Responsible For "Financial Statement Matters"

Cardinal's audit committee has identified employees responsible for accounting practices that are being investigated by the Securities & Exchange Commission and the New York U.S. Attorney's Office

Table

View full table

Topics

Tags:
BioPharmaceutical
Latest Headlines

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

See All
UsernamePublicRestriction

Register

PS059410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By